eli lilly mounjaro cardiovascular approval
Trending on Friday, August 28, 2026
Peak Traffic
2,000+
Related News
3
Country
US
Related News
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
Source: Reuters |
Read article →
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
Source: Eli Lilly and Company |
Read article →
Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease
Source: Bloomberg.com |
Read article →
Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients
Source: Fierce Pharma |
Read article →
Weight-loss drug may lower risk of heart attacks and infections
Source: Harvard Health |
Read article →